RESCHEDULED FOR MAY 5, 2021 – Treating man-made drug’s of abuse and overdose: a natural approach
In support of the Office of Personal Management guidance to strengthen efforts to protect the federal workforce and to ensure continuity of operations during the COVID-19 outbreak, the NIH Director is requesting that NIH-sponsored large meetings and symposia scheduled for May be held virtually, postponed, or cancelled.
Dr. Kim D. Janda is the Ely R. Callaway, Jr. Chaired Professor in the Departments of Chemistry, Immunology and Microbial Science at The Scripps Research Institute and is the Director of the Worm Institute of Research and Medicine. He is well known for his bridging of the fields of chemistry and immunology. Working at this interface he has shown how antibodies could be transformed from simple binding entities to catalysts. He pioneered treating drug addiction though immunopharmacotherapy, the creation of synthetic diversity methods, including phage display, and small molecule DNA encoding methodologies. He has published over 550 peer-reviewed papers.
The page was last updated on Tuesday, May 5, 2020 - 12:12pm